Claire Mazumdar's Net Worth
Claire Mazumdar's net worth is estimated to be at least $1,141,482.50 as of 04/06/2026. CoreStreet's estimation of Claire Mazumdar's net worth is based on their sale of stock and current holding of stock.
Claire Mazumdar is CEO at Bicara Therapeutics Inc. Common Stock. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,596 units of BCAX stock on 03/20/2026. Their biggest sale was on 03/09/2026 when they sold 36,766 units of Bicara Therapeutics Inc. Common Stock stock for $704,804.22. They typically trade 7 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $1,141,482.50
Most recent insider trade:
- March 20, 2026
Claire Mazumdar's Insider Trading History
| Bicara Therapeutics Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 20, 2026 | CEO | 1,596 | $18.95 | Sell | $30,244.20 |
March 19, 2026 | CEO | 6,905 | $18.78 | Sell | $129,675.90 |
March 18, 2026 | CEO | 6,499 | $18.84 | Sell | $122,441.16 |
March 9, 2026 | CEO | 36,766 | $19.17 | Sell | $704,804.22 |
March 6, 2026 | CEO | 3,817 | $18.75 | Sell | $71,568.75 |
March 5, 2026 | CEO | 1,786 | $18.74 | Sell | $33,469.64 |
March 4, 2026 | CEO | 2,631 | $18.73 | Sell | $49,278.63 |